TAK-954 Placebo

DRUG2 trials

Sponsors

Takeda, Millennium Pharmaceuticals, Inc.

Conditions

Healthy VolunteersPostoperative Gastrointestinal Dysfunction

Phase 1

A Study to Investigate the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of TAK-954 in Healthy Adult Participants

CompletedNCT03870555

Millennium Pharmaceuticals, Inc.Healthy Volunteers

Start: 2019-03-08End: 2019-05-16Updated: 2020-06-24

Phase 2

A Study of TAK-954 to Treat Gastrointestinal Dysfunction in Adults After Surgery

CompletedNCT03827655

TakedaPostoperative Gastrointestinal Dysfunction

Start: 2019-03-07End: 2022-05-27Updated: 2023-06-23

Related Papers

A randomized phase 2 study of the 5-HT<sub>4</sub> receptor agonist felcisetrag for postoperative gastrointestinal dysfunction after bowel surgery.

2024-04-271 citations